Cable Hill Partners, LLC Adverum Biotechnologies, Inc. Transaction History

Cable Hill Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$5.1 - $11.89 $12,750 - $29,725	-2,500 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$2.87 - $5.92 $1,435 - $2,960	500 Added 25.0%	2,500 $8,000
Q3 2018 Nov 14, 2018	SELL	$4.5 - $7.6 $6,750 - $11,400	-1,500 Reduced 42.86%	2,000 $11,000
Q2 2018 Aug 03, 2018	BUY	$5.3 - $6.9 $2,650 - $3,450	500 Added 16.67%	3,500 $19,000
Q4 2017 Feb 22, 2018	BUY	$2.85 - $3.95 $8,550 - $11,850	3,000	3,000 $13,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $660M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.